Skip to main content
$58.61 -$0.49 (-0.8%)

03:21 PM EDT on 05/16/22

Intra-Cellular Therapies Inc. (NASDAQ:ITCI)

CAPS Rating: No stars

Current Price $58.61 Mkt Cap $5.6B
Open $59.50 P/E Ratio 0.00
Prev. Close $59.10 Div. (Yield) $0.00 (0.0%)
Daily Range $58.00 - $60.02 Volume 501,761
52-Wk Range $28.40 - $66.00 Avg. Daily Vol. 970,533

Caps

How do you think NASDAQ:ITCI will perform against the market?

Add Stock to CAPS Watchlist

All Players

40 Outperform
6 Underperform
 

All-Star Players

7 Outperform
1 Underperform
 

Wall Street

0 Outperform
0 Underperform
 

Top NASDAQ:ITCI Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

odocoileus (< 20)
Submitted February 03, 2020

Was I lucky green-thumbing ITCI just before FDA approval? Well now that it's over I can pretty much say whatever I want. So, no, it was just savvy investing. I do better predicting FDA decisions than post approval sales. Seems regardless of market… More

Hendrickson71 (< 20)
Submitted January 06, 2016

Come on sugar factory, come down to earth already, Let's see some $40s this week,

NASDAQ:ITCI VS S&P 500 (SPY)

NASDAQ:ITCI Summary

Fools bullish on NASDAQ:ITCI are also bullish on:

Fools bearish on NASDAQ:ITCI are also bearish on:

Recent Community Commentary

Read the most recent pitches from players about ITCI.

Recs

2
Member Avatar odocoileus (< 20) Submitted: 2/2/2020 7:00:11 PM : Outperform Start Price: $12.32 NASDAQ:ITCI Score: +350.87

Was I lucky green-thumbing ITCI just before FDA approval? Well now that it's over I can pretty much say whatever I want. So, no, it was just savvy investing. I do better predicting FDA decisions than post approval sales. Seems regardless of market size or marketing muscle, it's a crapshoot for me whether the drug will take off. So here we are. ITCI has a new class of drug in a huge indication. I'm hanging on expecting big things. Tell me what I'm missing.

Recs

1
Member Avatar emtking (39.13) Submitted: 12/13/2019 1:05:50 PM : Outperform Start Price: $12.60 NASDAQ:ITCI Score: +341.67

New drug for bipolar disorder looks as close to a sure thing as there can be going into an FDA decision date of December 278th or sooner, 2019.

Recs

1
Member Avatar LifeScientist (43.95) Submitted: 2/17/2016 2:37:17 PM : Outperform Start Price: $30.57 NASDAQ:ITCI Score: -15.51

watch 27 is an entry

Leaderboard

Find the members with the highest scoring picks in ITCI.

Score Leader

baselineace

baselineace (25.02) Score: +371.97

Sometimes you just get lucky?

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
odocoileus < 20 12/11/2019 Outperform 5Y $12.32 +379.26% +28.39% +350.87 1 Comment
emtking 39.13 12/13/2019 Outperform 5Y $12.60 +368.61% +26.94% +341.67 1 Comment
derbydog85 42.24 12/23/2016 Outperform 5Y $15.62 +278.01% +78.74% +199.27 0 Comment
joe508mama 30.35 9/30/2016 Outperform 5Y $15.41 +283.16% +86.89% +196.27 0 Comment
warrenout 34.11 9/30/2016 Outperform 3M $15.41 +283.16% +86.89% +196.27 0 Comment
jmdor2222 79.53 9/29/2016 Outperform 5Y $15.49 +281.18% +87.00% +194.18 0 Comment
Dananator < 20 8/7/2020 Outperform 5Y $20.97 +181.64% +20.64% +161.00 0 Comment
12x < 20 3/4/2020 Outperform 5Y $21.73 +171.72% +31.47% +140.25 0 Comment
wackjob69 < 20 12/29/2014 Outperform 5Y $18.03 +227.48% +93.04% +134.44 0 Comment
TMFManaB < 20 12/2/2020 Outperform 1Y $24.85 +137.61% +10.08% +127.53 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for ITCI.